Hybrid Conferencee

International Conference on Cardiovascular Pharmacology and Drug Development (ICCP2D - 26)

27th - 28th November 2026 | Giza, Egypt

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Giza. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Giza event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Giza conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Giza, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Giza."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Call for Paper

The ICCP2D aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.

The conference highlights advancements in Cardiology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.

Authors are invited to submit papers addressing, but not limited to, the following areas:

01
Novel cardiovascular drugs development
02
Pharmacogenomics in cardiovascular therapy
03
Clinical trials in heart disease
04
Cardiovascular risk assessment tools
05
Innovations in heart failure management
06
Antihypertensive therapy advancements
07
Role of lifestyle in cardiovascular health
08
Patient adherence to cardiovascular medications
09
Emerging therapies for dyslipidemia
10
Cardiovascular disease prevention strategies
11
Impact of diabetes on heart health
12
Cardiovascular pharmacology education
13
Regulatory challenges in drug development
14
Telehealth in cardiovascular care
15
Ethical considerations in drug trials
16
Cardiovascular disease in diverse populations
17
Long-term effects of cardiovascular drugs
18
Integrative approaches to heart health
19
Cardiac rehabilitation innovations
20
Future trends in cardiovascular pharmacology